Literature DB >> 20297953

Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study.

M C F Prosperi1, A Cozzi-Lepri, A Castagna, C Mussini, R Murri, A Giacometti, C Torti, A Costantini, P Narciso, F Ghinelli, A Antinori, A d'Arminio Monforte.   

Abstract

The incidence of and predictors of acquired immunodeficiency syndrome-defining malignancies (ADMs) and non-ADM (NADMs) were evaluated in a large Italian cohort. The incidence of ADM and NADM was 5.0 cases per 1000 person-years of follow-up (95% confidence interval, 4.3-5.8 cases per 1000 person-years of follow-up) and 2.4 cases per 1000 person-years of follow-up (95% confidence interval, 1.9-3.1 cases per 1000 person-years of follow-up), respectively. Lower current CD4 cell count was an independent predictor of developing malignancies, with the association being stronger for ADM than for NADM.

Entities:  

Mesh：

Year:  2010        PMID： 20297953     DOI： 10.1086/651688

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  22 in total

1.  Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis.

Authors:  Supriya Krishnan; Jeffrey T Schouten; Denise L Jacobson; Constance A Benson; Ann C Collier; Susan L Koletar; Jorge Santana; Fred R Sattler; Ronald Mitsuyasu
Journal:  Oncology       Date:  2011-05-23       Impact factor: 2.935

2.  Non-AIDS-Defining Malignancies in the HIV-Infected Population.

Authors:  Chia-Ching J Wang; Michael J Silverberg; Donald I Abrams
Journal:  Curr Infect Dis Rep       Date:  2014-06       Impact factor: 3.725

Review 3.  Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.

Authors:  Anna C Hearps; Genevieve E Martin; Reena Rajasuriar; Suzanne M Crowe
Journal:  Curr HIV/AIDS Rep       Date:  2014-03       Impact factor: 5.071

4.  HIV infection, immunodeficiency, viral replication, and the risk of cancer.

Authors:  Michael J Silverberg; Chun Chao; Wendy A Leyden; Lanfang Xu; Michael A Horberg; Daniel Klein; William J Towner; Robert Dubrow; Charles P Quesenberry; Romain S Neugebauer; Donald I Abrams
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-22       Impact factor: 4.254

5.  Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy.

Authors:  Suchita Pakkala; Zhengjia Chen; David Rimland; Taofeek K Owonikoko; Clifford Gunthel; Johann R Brandes; Nabil R Saba; Dong M Shin; Walter J Curran; Fadlo R Khuri; Suresh S Ramalingam
Journal:  Cancer       Date:  2011-06-28       Impact factor: 6.860

Review 6.  Non-AIDS-defining cancers among HIV-infected patients.

Authors:  James Cutrell; Roger Bedimo
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

7.  Mortality and immunological recovery among older adults on antiretroviral therapy at a large urban HIV clinic in Kampala, Uganda.

Authors:  Aggrey S Semeere; Isaac Lwanga; Joseph Sempa; Sujal Parikh; Noeline Nakasujja; Robert Cumming; Andrew Kambugu; Harriet Mayanja-Kizza
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-01       Impact factor: 3.731

Review 8.  Incidence and risk of lung cancer in HIV-infected patients.

Authors:  Wenli Hou; Jun Fu; Yuanyuan Ge; Jian Du; Shucheng Hua
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-28       Impact factor: 4.553

9.  History of AIDS in HIV-Infected Patients Is Associated With Higher In-Hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke.

Authors:  Nwora Lance Okeke; Charles B Hicks; Mehri S McKellar; Vance G Fowler; Jerome J Federspiel
Journal:  J Infect Dis       Date:  2016-03-03       Impact factor: 5.226

10.  Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.

Authors:  Chun Chao; Wendy A Leyden; Lanfang Xu; Michael A Horberg; Daniel Klein; William J Towner; Charles P Quesenberry; Donald I Abrams; Michael J Silverberg
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.